THIS IS A COMPLIMENTARY PROGRAM
- For the most optimal streaming and interactive experience, we recommend using Firefox or Google Chrome browsers.
- The webinar will not display correctly using Internet Explorer.
- Click on the following link to download Firefox: www.firefox.com
- Click on the following link to download Google Chrome: https://www.google.com/chrome/
- Hit Play in the video player to begin the live broadcast.
- If you have trouble seeing the video stream:
- Click the Refresh Stream button under video player
- Try using Google Chrome web browser
- If you have trouble hearing the audio:
- Increase the volume inside the video player above
- Increase the volume on your computer speakers
- If viewing as a group: please contact Lauren Wills at the contact information below and we will email the appropriate documentation to receive CME/CE credit.
- For technical assistance: please email lrivera@frontpageproductions.com
- For other questions or assistance: please contact Lauren Wills at lwills@talemhealth.com or (800) 913-9370 ext. 3
Where:
www.ruralhealthcme.com
Cost:
Complimentary
Contact Us:
For questions regarding this CME/CE activity, please contact:
Lauren Wills by phone, 800-913-9370 ext. 705 or email, lwills@talemhealth.com.
Talem Health, LLC
105 Technology Drive, Suite G4
Trumbull, CT 06611
LEARNING OBJECTIVES
After completing this activity, participants should be better able to:
- Describe the epidemiology and risk factors for invasive fungal infections in patients who are immunocompromised and/or immunosuppressed.
- Employ the latest diagnostic techniques for invasive fungal infections to ensure early diagnosis and timely initiation of treatment.
- Integrate evidence-based guidelines on the use of antifungal agents, and the pharmacokinetic/pharmacodynamic characteristics of these agents, into treatment decisions for patients with invasive fungal infections.
FACULTY
Peter G. Pappas, MD, FACP (Program Chair)
William E. Dismukes Professor of Medicine
Principal Investigator, Mycoses Study Group Education and Research Consortium
Division of Infectious Diseases
University of Alabama at Birmingham
Birmingham, Alabama
Rhett M. Shirley, MD
Assistant Professor of Clinical Internal Medicine
University of South Carolina School of Medicine
Infectious Disease Specialist
GHS Greenville Memorial Hospital
Greenville, South Carolina
TARGET AUDIENCE
This program is designed specifically for infectious disease specialists, internal medicine specialists and other health care professionals involved in the treatment of patients with or at risk for invasive fungal infections.
AGENDA
- Introduction
- Epidemiology and Risks Factors
- Advances in Diagnosis of Invasive Fungal Infections
- Strategies to Optimize Antifungal Therapy
- Case-based Discussion
ACCREDITATION
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and Talem Health. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity is jointly provided by Boston University School of Medicine and Talem Health, LLC.
Physicians
Boston University School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses
This educational activity has been provided by Continuing Nursing Education Provider Unit, Boston University School of Medicine and jointly provided by Talem Health.
Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
Contact Hours: 1.0
Disclosure Policy
Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
Faculty
Dr. Pappas has disclosed that he receives grant support from Astellas Pharma US, Inc., Gilead Sciences Inc., Imprimis Pharmaceuticals Inc., and Scynexis.
Dr. Shirley has no financial relationships to disclose.
Faculty members do not plan on discussing unlabeled/investigational uses of a commercial product.
Planning Committee
Stuart M. Levitz, MD, Course Director, University of Massachusetts Medical School
Carolynn Thomas Jones, DNP, MSPH, BSN, RN, Nurse Advisor, Ohio State University
Joanna Krause, MPH, Grants Manager, Boston University School of Medicine, CME
Erica Rusie, PharmD, Senior Director, Scientific Affairs, Talem Health, LLC
Carrie Noriega, MD, Medical Writer, Talem Health, LLC
The members of the Planning Committee have no relevant financial relationships to disclose.
ACKNOWLEDGMENT
This activity is supported by an educational grant from Astellas Pharma US, Inc.
This activity is being developed in collaboration with the National Rural Health Association.
Disclaimer
ALL PROGRAMS, ACTIVITIES, AND MATERIALS PROVIDED BY BOSTON UNIVERSITY OFFICE OF CONTINUING MEDICAL EDUCATION OR ITS ASSOCIATES ARE PROVIDED ON THE CONDITION THAT THEY BE USED SOLELY FOR EDUCATIONAL PURPOSES BY QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE CONTINUING MEDICAL EDUCATION PROGRAMS, ACTIVITIES OR MATERIALS. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED.
©Talem Health, LLC 2018. All Rights Reserved.